On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
In this review, we will discuss the safety of repeated treatments with ketamine for patients with treatment-resistant depression (TRD), a condition in which patients with major depression do not show any clinical improvements following treatments with at least two antidepressant drugs. We will discuss the effects of these treatments in both sexes at different developmental periods. Numerous small clinical studies have shown that a single, low-dose ketamine infusion can rapidly alleviate depressive symptoms and thoughts of suicidality in patients with TRD, and these effects can last for about one week. Interestingly, the antidepressant effects of ketamine can be prolonged with intermittent, repeated infusion regimens and produce more robust therapeutic effects when compared to a single infusion. The safety of such repeated treatments with ketamine has not been thoroughly investigated. Although more studies are needed, some clinical and preclinical reports indicated that repeated infusions of low doses of ketamine may have addictive properties, and suggested that adolescent and adult female subjects may be more sensitive to ketamine's addictive effects. Additionally, during ketamine infusions, many TRD patients report hallucinations and feelings of dissociation and depersonalization, and therefore the effects of repeated treatments of ketamine on cognition must be further examined. Some clinical reports indicated that, compared to women, men are more sensitive to the psychomimetic effects of ketamine. Preclinical studies extended these findings to both adolescent and adult male rodents and showed that male rodents at both developmental periods are more sensitive to ketamine's cognitive-altering effects. Accordingly, in this review we shall focus our discussion on the potential addictive and cognitive-impairing effects of repeated ketamine infusions in both sexes at two important developmental periods: adolescence and adulthood. Although more work about the safety of ketamine is warranted, we hope this review will bring some answers about the safety of treating TRD with repeated ketamine infusions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786 · cited 6×
“duration of antidepressant response after cessation of treatment (aan het Rot et al., 2010; Murrough et al., 2013; Shiroma et al., 2014a).”
BackgroundMethodResultInfluentialWilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040472 · Cited by 696
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Felger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620
Scofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598 · cited 3×
“drug injection) to ascertain positive (CPP) or negative (CPA) associations between the two stimuli (Tzschentke, 2007; Scofield et al., 2016).”
BackgroundDiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05327blu · Cited by 564 · cited 1×
“However, following acute ketamine treatment, most patients remitted (DiazGranados et al., 2010; Zarate et al., 2006), suggesting a need for repeated infusions to maintain long-term therapeutic efficacy.”
BackgroundInfluentialBerlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412
Morgan, C. J. A., Muetzelfeldt, L., & Curran, H. V. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02761.x · Cited by 373
Dysfunctional reward processing in depression
Admon, R., & Pizzagalli, D. A. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.011 · Cited by 343
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.027 · Cited by 286
Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating
Kristensen, A. S., Jenkins, M. A., Banke, T. G., Schousboe, A., Makino, Y., Johnson, R. C., Huganir, R., & Traynelis, S. F. (2011) · Nature Neuroscience · doi:10.1038/nn.2804 · Cited by 286 · cited 2×
“Indeed, acute infusion of ketamine (0.5 mg/kg, i.v.) re-activated states of psychosis in many schizophrenic patients tested (Lahti et al., 1995).”
BackgroundInfluentialDo the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283
Sex differences in the antidepressant-like effects of ketamine
Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251
Self-citationClinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Niciu, M. J., Luckenbaugh, D. A., Ionescu, D. F., Guevara, S., Machado-Vieira, R., Richards, E. M., Brutsche, N. E., Nolan, N. M., & Zarate, C. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08698 · Cited by 165 · cited 1×
“, 2005), and a recent report found no evidence of gender nor age being significant predictors of ketamine's antidepressant efficacy (Niciu et al., 2014).”
BackgroundMolecular mechanisms underlying alcohol-drinking behaviours
Ron, D., & Barak, S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.85 · Cited by 165
Tuscher, J. J., Luine, V., Frankfurt, M., & Frick, K. M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3135-15.2016 · Cited by 149
Murrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., Foulkes, A., Charney, D. S., Mathew, S. J., & Iosifescu, D. V. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.298 · Cited by 142
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Lener, M. S., Kadriu, B., & Zarate, C. A. (2017) · Drugs · doi:10.1007/s40265-017-0702-8 · Cited by 131
Shiroma, P. R., Albott, C. S., Johns, B., Thuras, P., Wels, J., & Lim, K. O. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714001011 · Cited by 126
The role of adipokines in the rapid antidepressant effects of ketamine
Machado-Vieira, R., Gold, P. W., Luckenbaugh, D. A., Ballard, E. D., Richards, E. M., Henter, I. D., De Sousa, R. T., Niciu, M. J., Yuan, P., & Zarate, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.36 · Cited by 102 · cited 1×
“Furthermore, other baseline alterations in TRD patients as compared to healthy subjects, such as elevated levels of inflammatory cytokines and adipokines, have been reported and indicate different metabolism profiles which may impact sensitivity to a drug over time (Kiraly et al., 2017; Machado-Vieira et al., 2017).”
BackgroundGender differences in subjective discontinuation symptoms associated with ketamine use
Chen, W.-Y., Huang, M.-C., & Lin, S.-K. (2014) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-9-39 · Cited by 87
Ketamine for Depression, 3: Does Chirality Matter?: (Clinical and Practical Psychopharmacology)
Andrade, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17f11681 · Cited by 78
Quevedo, K., Ng, R., Scott, H., Kodavaganti, S., Smyda, G., Diwadkar, V., & Phillips, M. (2017) · Biological Psychology · doi:10.1016/j.biopsycho.2016.11.004 · Cited by 53
RNA-Seq Reveals Novel Transcriptional Reorganization in Human Alcoholic Brain
Farris, S. P., & Dayne Mayfield, R. (2014) · International Review of Neurobiology · doi:10.1016/b978-0-12-801105-8.00011-4 · Cited by 49
Ketamine prevents stress-induced cognitive inflexibility in rats
Nikiforuk, A., & Popik, P. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.009 · Cited by 39
Research works printed but not linked: 99
- Adler, 1998, Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers, Biol. Psychiatr., 43, 811, 10.1016/S0006-3223(97)00556-8 · DOI · Paper page
- Andrews, 2002, Preventing major depression in young people, Br. J. Psychiatry, 181, 460, 10.1192/bjp.181.6.460 · DOI
- Bartoli, 2017, Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis, Neurosci. Biobehav. Rev., 77, 232, 10.1016/j.neubiorev.2017.03.010 · DOI
- Becker, 2003, Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 27, 687, 10.1016/S0278-5846(03)00080-0 · DOI · Paper page
- Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol. Psychiatr., 47, 351, 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
- Bonnet, 2015, Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction, J. Psychoact. Drugs, 47, 276, 10.1080/02791072.2015.1072653 · DOI · Paper page
- Botanas, 2015, Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential, Pharmacol. Biochem. Behav., 133, 31, 10.1016/j.pbb.2015.03.007 · DOI
- Caffino, 2016, The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: effects of single infusion vs. chronic self-administration in rats, Pharmacol. Res., 104, 22, 10.1016/j.phrs.2015.12.014 · DOI
- Caffino, 2017, Ketamine self-administration elevates alphaCaMKII autophosphorylation in mood and reward-related brain regions in rats, Mol. Neurobiol., 55, 5453, 10.1007/s12035-017-0772-3 · DOI
- Camarini, 2016, Behavioral sensitization to ethanol: neural basis and factors that influence its acquisition and expression, Brain Res. Bull., 125, 53, 10.1016/j.brainresbull.2016.04.006 · DOI · Paper page
- Celia Moreira Borella, 2016, Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine, Dev. Neurobiol., 76, 519, 10.1002/dneu.22329 · DOI
- Chang, 2016, Major depressive disorder induced by chronic ketamine abuse: a case report, Prim. Care Companion CNS Disord., 18
- Cho, 2005, Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine, Psychopharmacology (Berl), 179, 136, 10.1007/s00213-004-2066-5 · DOI
- Cohen, 2015, Assessing rodent hippocampal involvement in the novel object recognition task. A review, Behav. Brain Res., 285, 105, 10.1016/j.bbr.2014.08.002 · DOI · Paper page
- Costumero, 2017, Left frontoparietal network activity is modulated by drug stimuli in cocaine addiction, Brain Imag. Behav.
- Curran, 2001, In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users, Addiction, 96, 749, 10.1046/j.1360-0443.2001.96574910.x · DOI · Paper page
- Cusin, 2017, Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation, Aust. N. Z. J. Psychiatr., 51, 55, 10.1177/0004867416631828 · DOI · Paper page
- D'Souza, 2012, Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia, Biol. Psychiatr., 72, 785, 10.1016/j.biopsych.2012.05.009 · DOI
- De Luca, 2011, Ketamine self-administration in the rat: evidence for a critical role of setting, Psychopharmacology (Berl), 214, 549, 10.1007/s00213-010-2062-x · DOI · Paper page
- Diamond, 2014, Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic, J. Psychopharmacol., 28, 536, 10.1177/0269881114527361 · DOI · Paper page
- Dodman, 2015, Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice, Drug Alcohol Depend., 156, 14, 10.1016/j.drugalcdep.2015.07.1198 · DOI
- Dossat, 2018, Behavioral and biochemical sensitivity to low doses of ketamine: influence of estrous cycle in C57BL/6 mice, Neuropharmacology, 130, 30, 10.1016/j.neuropharm.2017.11.022 · DOI · Paper page
- Doyle, 2013, Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents, J. Pharmacol. Exp. Therapeut., 345, 151, 10.1124/jpet.112.201665 · DOI
- Evans, 2012, The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium spiny neurons, PLoS Comput. Biol., 8, 10.1371/journal.pcbi.1002493 · DOI
- Featherstone, 2012, Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice, Neurobiol. Dis., 47, 338, 10.1016/j.nbd.2012.05.003 · DOI · Paper page
- Franceschelli, 2015, Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naive and "depressed" mice exposed to chronic mild stress, Neuroscience, 290, 49, 10.1016/j.neuroscience.2015.01.008 · DOI · Paper page
- Fu, 2012, Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice, Drug Metab. Dispos., 40, 1216, 10.1124/dmd.111.044461 · DOI
- Gazzaley, 1996, Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus, J. Neurosci., 16, 6830, 10.1523/JNEUROSCI.16-21-06830.1996 · DOI · Paper page
- Gierski, 2013, Executive functions in adult offspring of alcohol- dependent probands: toward a cognitive endophenotype?, Alcohol Clin. Exp. Res., 37, E356
- Hampson, 1990, Estrogen-related variations in human spatial and articulatory-motor skills, Psychoneuroendocrinology, 15, 97, 10.1016/0306-4530(90)90018-5 · DOI · Paper page
- Hauser, 2017, Disturbances of novel object exploration and recognition in a chronic ketamine mouse model of schizophrenia, Behav. Brain Res., 332, 316, 10.1016/j.bbr.2017.06.013 · DOI
- Jamadar, 2012, Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism, Psychopharmacology (Berl), 222, 129, 10.1007/s00213-011-2628-2 · DOI
- Kaminer, 2007, Comorbid adolescent substance use and major depressive disorders: a review, Psychiatry (Edgmont), 4, 32
- Keilhoff, 2004, Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia, Neuroscience, 126, 591, 10.1016/j.neuroscience.2004.03.039 · DOI · Paper page
- Kekesi, 2015, Sex-specific alterations in behavioral and cognitive functions in a "three hit" animal model of schizophrenia, Behav. Brain Res., 284, 85, 10.1016/j.bbr.2015.02.015 · DOI
- Kiraly, 2017, Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome, Transl. Psychiatry, 7, e1065, 10.1038/tp.2017.31 · DOI · Paper page
- Kos, 2011, The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice, Psychopharmacology (Berl), 214, 911, 10.1007/s00213-010-2102-6 · DOI · Paper page
- Lahti, 1995, Ketamine activates psychosis and alters limbic blood flow in schizophrenia, Neuroreport, 6, 869, 10.1097/00001756-199504190-00011 · DOI · Paper page
- Lahti, 2001, Effects of ketamine in normal and schizophrenic volunteers, Neuropsychopharmacology, 25, 455, 10.1016/S0893-133X(01)00243-3 · DOI · Paper page
- Laurie, 1997, Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies, Brain Res. Mol. Brain Res., 51, 23, 10.1016/S0169-328X(97)00206-4 · DOI · Paper page
- Li, 2008, Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats, Eur. J. Pharmacol., 589, 122, 10.1016/j.ejphar.2008.04.051 · DOI
- Liang, 2013, Cognitive impairments in poly-drug ketamine users, Addict. Behav., 38, 2661, 10.1016/j.addbeh.2013.06.017 · DOI
- Liang, 2015, Ketamine users have high rates of psychosis and/or depression, J. Addict. Nurs., 26, 8, 10.1097/JAN.0000000000000060 · DOI
- Majewski-Tiedeken, 2008, Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains, Drug Alcohol Depend., 92, 217, 10.1016/j.drugalcdep.2007.08.009 · DOI
- Malhotra, 1996, NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers, Neuropsychopharmacology, 14, 301, 10.1016/0893-133X(95)00137-3 · DOI · Paper page
- McDougall, 2017, Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose, Psychopharmacology (Berl), 234, 2683, 10.1007/s00213-017-4660-3 · DOI
- McGowan, 2017, Prophylactic ketamine attenuates learned fear, Neuropsychopharmacology, 42, 1577, 10.1038/npp.2017.19 · DOI
- Monyer, 1994, Developmental and regional expression in the rat brain and functional properties of four NMDA receptors, Neuron, 12, 529, 10.1016/0896-6273(94)90210-0 · DOI · Paper page
- Morgan, 2006, Greater vulnerability to the amnestic effects of ketamine in males, Psychopharmacology (Berl), 187, 405, 10.1007/s00213-006-0409-0 · DOI · Paper page
- Muthukumaraswamy, 2015, Evidence that subanesthetic doses of ketamine cause sustained disruptions of NMDA and AMPA-mediated frontoparietal connectivity in humans, J. Neurosci., 35, 11694, 10.1523/JNEUROSCI.0903-15.2015 · DOI · Paper page
- Nagy, 2015, Delayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in mice, Transl. Psychiatry, 5, e635, 10.1038/tp.2015.111 · DOI
- Narendran, 2005, Altered prefrontal dopaminergic function in chronic recreational ketamine users, Am. J. Psychiatr., 162, 2352, 10.1176/appi.ajp.162.12.2352 · DOI · Paper page
- Neill, 2010, Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism, Pharmacol. Ther., 128, 419, 10.1016/j.pharmthera.2010.07.004 · DOI · Paper page
- Newcomer, 1999, Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis, Neuropsychopharmacology, 20, 106, 10.1016/S0893-133X(98)00067-0 · DOI · Paper page
- Ng, 2017, Depression and substance use comorbidity: what we have learned from animal studies, Am. J. Drug Alcohol Abuse, 43, 456, 10.1080/00952990.2016.1183020 · DOI
- Nikiforuk, 2014, The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats, Eur. Neuropsychopharmacol, 24, 1381, 10.1016/j.euroneuro.2014.04.007 · DOI
- Nugent, 2014, Neural correlates of rapid antidepressant response to ketamine in bipolar disorder, Bipolar Disord., 16, 119, 10.1111/bdi.12118 · DOI · Paper page
- Ontl, 2004, Development and aging of N-methyl-D-aspartate receptor expression in the prefrontal/frontal cortex of mice, Neuroscience, 123, 467, 10.1016/j.neuroscience.2003.09.006 · DOI
- Papakostas, 2003, Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder, J. Clin. Psychiatr., 64, 1357, 10.4088/JCP.v64n1112 · DOI · Paper page
- Pare, 1993, Sex differences and stress response of WKY rats, Physiol. Behav., 54, 1179, 10.1016/0031-9384(93)90345-G · DOI · Paper page
- Parise, 2013, Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats, Biol. Psychiatr., 74, 750, 10.1016/j.biopsych.2013.04.027 · DOI · Paper page
- Paul, 2010, NR2B-NMDA receptor-mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling, J. Neurochem., 114, 1107, 10.1111/j.1471-4159.2010.06835.x · DOI
- Petrakis, 2004, Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism, Am. J. Psychiatr., 161, 1776, 10.1176/ajp.161.10.1776 · DOI · Paper page
- Phelps, 2009, Family history of alcohol dependence and initial antidepressant response to an N- methyl-D-aspartate antagonist, Biol. Psychiatr., 65, 181, 10.1016/j.biopsych.2008.09.029 · DOI · Paper page
- Roca, 2015, Cognitive impairments and depression: a critical review, Actas Esp. Psiquiatr., 43, 187
- Rocha, 2017, Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration, Pharmacol. Biochem. Behav., 157, 24, 10.1016/j.pbb.2017.04.007 · DOI
- Rustay, 2001, Sensitivity and tolerance to ethanol-induced incoordination and hypothermia in HAFT and LAFT mice, Pharmacol. Biochem. Behav., 70, 167, 10.1016/S0091-3057(01)00595-0 · DOI
- Saland, 2017, Integrative analysis of sex differences in the rapid antidepressant effects of ketamine in preclinical models for individualized clinical outcomes, Curr. Opin. Behav. Sci., 14, 19, 10.1016/j.cobeha.2016.11.002 · DOI
- Sans, 2000, Postnatal developmental changes in AMPA and NMDA receptors in the rat vestibular nuclei, Brain Res. Dev. Brain Res., 123, 41, 10.1016/S0165-3806(00)00082-1 · DOI
- Santamaria, 2014, In vitro ketamine CYP3A-mediated metabolism study using mammalian liver S9 fractions, cDNA expressed enzymes and liquid chromatography tandem mass spectrometry, Biomed. Chromatogr., 28, 1660, 10.1002/bmc.3199 · DOI
- Schak, 2016, Potential risks of poorly monitored ketamine use in depression treatment, Am. J. Psychiatr., 173, 215, 10.1176/appi.ajp.2015.15081082 · DOI
- Schoepfer, 2017, Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats, Physiol. Behav.
- Seshadri, 2018, Altered avalanche dynamics in a developmental NMDAR hypofunction model of cognitive impairment, Transl. Psychiatry, 8, 3, 10.1038/s41398-017-0060-z · DOI
- Shen, 2011, Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors, Proc. Natl. Acad. Sci. U. S. A., 108, 19407, 10.1073/pnas.1112052108 · DOI · Paper page
- Shiroma, 2014, Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression, J. Affect. Disord., 155, 123, 10.1016/j.jad.2013.10.036 · DOI · Paper page
- Silvestre de Ferron, 2015, Two binges of ethanol a day keep the memory away in adolescent rats: key role for GLUN2B subunit, Int. J. Neuropsychopharmacol., 19, 10.1093/ijnp/pyv087 · DOI
- Sos, 2013, Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression, Neuroendocrinol. Lett., 34, 287
- Spear, 2000, The adolescent brain and age-related behavioral manifestations, Neurosci. Biobehav. Rev., 24, 417, 10.1016/S0149-7634(00)00014-2 · DOI · Paper page
- Stefanovic, 2009, Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?, J. Clin. Psychopharmacol., 29, 124, 10.1097/JCP.0b013e31819a4b91 · DOI
- Strong, 2017, Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats, Neuropharmacology, 121, 195, 10.1016/j.neuropharm.2017.05.003 · DOI
- Sundermann, 2016, Female advantage in verbal memory: evidence of sex-specific cognitive reserve, Neurology, 87, 1916, 10.1212/WNL.0000000000003288 · DOI · Paper page
- Suzuki, 2000, Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice, Life Sci., 67, 383, 10.1016/S0024-3205(00)00639-1 · DOI
- Tang, 2015, Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia, Psychopharmacology (Berl), 232, 1515, 10.1007/s00213-014-3782-0 · DOI
- Thelen, 2016, Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice, Behav. Brain Res., 312, 305, 10.1016/j.bbr.2016.06.041 · DOI
- Tizabi, 2012, Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats, Neuroscience, 213, 72, 10.1016/j.neuroscience.2012.03.052 · DOI · Paper page
- Tsujimoto, 2008, The prefrontal cortex: functional neural development during early childhood, Neuroscientist, 14, 345, 10.1177/1073858408316002 · DOI · Paper page
- Tuscher, 2016, Inhibition of local estrogen synthesis in the hippocampus impairs hippocampal memory consolidation in ovariectomized female mice, Horm. Behav., 83, 60, 10.1016/j.yhbeh.2016.05.001 · DOI · Paper page
- Van den Buuse, 2001, Estrogen increases prepulse inhibition of acoustic startle in rats, Eur. J. Pharmacol., 425, 33, 10.1016/S0014-2999(01)01139-6 · DOI
- van den Buuse, 2015, Chronic estrogen and progesterone treatment inhibits ketamine-induced disruption of prepulse inhibition in rats, Neurosci. Lett., 607, 72, 10.1016/j.neulet.2015.09.019 · DOI
- van der Kam, 2007, Effect of 2-methyl-6- (phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat, Behav. Pharmacol., 18, 717, 10.1097/FBP.0b013e3282f18d58 · DOI
- Venniro, 2015, Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in rats, Psychopharmacology (Berl), 232, 4505, 10.1007/s00213-015-4077-9 · DOI
- Vetter-O'Hagen, 2012, Hormonal and physical markers of puberty and their relationship to adolescent-typical novelty-directed behavior, Dev. Psychobiol., 54, 523, 10.1002/dev.20610 · DOI · Paper page
- World Health Organization (WHO), 2012, Ketamine: expert peer review on critical review report. WHO: hammamet, Tunisia, June 4-8
- Wiley, 2008, Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats, Addict. Biol., 13, 277, 10.1111/j.1369-1600.2007.00077.x · DOI
- Wiley, 2011, Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug, Pharmacol. Rep., 63, 1085, 10.1016/S1734-1140(11)70627-2 · DOI
- Wise, 2014, The development and maintenance of drug addiction, Neuropsychopharmacology, 39, 254, 10.1038/npp.2013.261 · DOI · Paper page
- Wright, 2017, Reinforcing properties of an intermittent, low dose of ketamine in rats: effects of sex and cycle, Psychopharmacology (Berl), 234, 393, 10.1007/s00213-016-4470-z · DOI
- Zheng, 2017, Function of 38 variants CYP2C9 polymorphism on ketamine metabolism in vitro, J. Pharmacol. Sci., 135, 8, 10.1016/j.jphs.2017.08.006 · DOI
- Zhou, 2011, Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol, Proc. Natl. Acad. Sci. U. S. A., 108, 6626, 10.1073/pnas.1018514108 · DOI · Paper page
Cited by
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
The impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87
“…that the antisuicidal effects of ketamine are long-lasting (Zalsman et al., 2016; Dadiomov and Lee, 2019) and there are significant concerns surrounding repeated administration of ketamine, including the potential for abuse and cognitive impairment (Schak et al., 2016; Strong and Kabbaj, 2018).”
BackgroundZeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67
Millard, S. J., Weston-Green, K., & Newell, K. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109908 · Cited by 62
Mandal, G., Kirkpatrick, M., Alboni, S., Mariani, N., Pariante, C. M., & Borsini, A. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae041 · Cited by 15
“However, the use of ketamine could have adverse outcomes due to its addictive properties and psychotomimetic effects (Strong and Kabbaj, 2018).”
Metadata
- Authors
- Strong, C. E., & Kabbaj, M.
- Venue
- Neurobiology of Stress
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 9
- Pages
- 166-175
- ISSN
- 2352-2895 (ISSN-L)
- OpenAlex
- W2891058443
- Cited by
- 60
- References
- 31
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institute of Mental Health (MH190450, R01 MH099085)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.